Léa Guyonnet
Impact in
- Nephrology top 5%
- Renal Diseases and Glomerulopathies
- Chronic Kidney Disease and Diabetes
- Genetics top 10%
- Glioma Diagnosis and Treatment
Papers in
-
- Renal Diseases and Glomerulopathies 7
- Genetics 3
- Chronic Lymphocytic Leukemia Research 1
- Co-authors
- Pierre‐Louis Tharaux (10 shared papers)Olivia Lenoir (8 shared papers)Anna Chipont (6 shared papers)Carole Hénique (4 shared papers)Michèle Souyri (2 shared papers)Alain Schmitt (1 shared paper)Jean‐Marc Massé (1 shared paper)Tobias Bruno Huber (1 shared paper)
- Journals
- Nature Communications (6 papers)Kidney International (3 papers)Stem Cell Reviews and Reports (2 papers)Blood (1 paper)Arteriosclerosis Thrombosis and Vascular Biology (1 paper)
- Partner nations
- FranceLuxembourgUnited Kingdom
In The Last Decade
Léa Guyonnet
28 papers receiving 1.1k citations
Léa Guyonnet's Hit Papers
Peers
Comparison fields: 5 of 70
- Nephrology 283
- Genetics 130
- Oncology 192
- Immunology 115
- Epidemiology 116
Countries citing papers authored by Léa Guyonnet
This map shows the geographic impact of Léa Guyonnet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Léa Guyonnet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Léa Guyonnet more than expected).
Fields of papers citing papers by Léa Guyonnet
This network shows the impact of papers produced by Léa Guyonnet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Léa Guyonnet. The network helps show where Léa Guyonnet may publish in the future.
Co-authors
The 25 scholars most cited alongside Léa Guyonnet, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 252 | |
| 2 | Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial Hit paper breakdown → | 2024 | 133 |
| 3 | 2018 | 117 | |
| 4 | 2020 | 68 | |
| 5 | 2019 | 64 | |
| 6 | 2018 | 55 | |
| 7 | 2017 | 48 | |
| 8 | 2017 | 39 | |
| 9 | 2024 | 38 | |
| 10 | 2017 | 35 | |
| 11 | 2018 | 33 | |
| 12 | 2023 | 30 | |
| 13 | 2014 | 29 | |
| 14 | 2021 | 25 | |
| 15 | 2020 | 22 | |
| 16 | 2017 | 20 | |
| 17 | 2021 | 20 | |
| 18 | 2023 | 20 | |
| 19 | 2023 | 14 | |
| 20 | 2020 | 10 |
About Léa Guyonnet
Léa Guyonnet is a scholar working on Nephrology, Genetics, Immunology, Oncology and Physiology, having authored 29 papers that have together received 1.1k indexed citations. Recurring topics across this work include Renal Diseases and Glomerulopathies (7 papers), Nitric Oxide and Endothelin Effects (3 papers), Cancer Immunotherapy and Biomarkers (2 papers), Mechanical Circulatory Support Devices (2 papers), RNA Research and Splicing (2 papers), Atherosclerosis and Cardiovascular Diseases (2 papers), Cancer, Hypoxia, and Metabolism (1 paper) and Chronic Lymphocytic Leukemia Research (1 paper). The work is most often cited by research in Nephrology (283 citations), Genetics (130 citations), Oncology (192 citations), Immunology (115 citations) and Epidemiology (116 citations). Léa Guyonnet has collaborated with scholars based in France, Luxembourg and United Kingdom. Frequent co-authors include Pierre‐Louis Tharaux, Olivia Lenoir, Anna Chipont, Carole Hénique, Michèle Souyri, Alain Schmitt, Jean‐Marc Massé, Tobias Bruno Huber, Kathleen Flosseau and Björn Hartleben. Their work appears in journals such as Nature Communications, Kidney International, Stem Cell Reviews and Reports, Blood and Arteriosclerosis Thrombosis and Vascular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.